Neuroscience

Neuroscience

With one of the strongest pipelines in the industry, Roche Neuroscience is developing medicines for a range of serious neurological diseases, including multiple sclerosis, Alzheimer’s disease, autism, spinal muscular atrophy, depression, Parkinson’s disease, Down syndrome.

Diseases of the central nervous system

Diseases of the central nervous system

By carrying out in-depth research into the central nervous system, we strive to uncover new ways of diagnosing and treating Alzheimer's disease and schizophrenia. 

more about the central nervous system

Multiple sclerosis

multiple sclerosis

Multiple sclerosis (MS) is a disease of the central nervous system. MS can disrupt signals within the brain, spinal cord and optic nerves, leading to a wide range of symptoms and disability. Roche is developing new approaches to understand and treat this chronic and debilitating illness.

more about multiple sclerosis

Research in Germany

Research in Germany

The research-intensive Pharma and Diagnostics divisions focus on medical solutions in areas of significant unmet medical need.

more about research in Germany